These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19348472)
21. Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). Cooper TW; Campbell IB; Macdonald SJ Angew Chem Int Ed Engl; 2010 Oct; 49(44):8082-91. PubMed ID: 20859975 [TBL] [Abstract][Full Text] [Related]
22. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1. Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055 [TBL] [Abstract][Full Text] [Related]
23. Systematic enumeration of heteroaromatic ring systems as reagents for use in medicinal chemistry. Ward RA; Kettle JG J Med Chem; 2011 Jul; 54(13):4670-7. PubMed ID: 21650161 [TBL] [Abstract][Full Text] [Related]
24. Indenylmetal Catalysis in Organic Synthesis. Trost BM; Ryan MC Angew Chem Int Ed Engl; 2017 Mar; 56(11):2862-2879. PubMed ID: 27806434 [TBL] [Abstract][Full Text] [Related]
25. Synthetic studies of heterocyclic natural products. Joullié MM; Berritt S; Forbeck EM Curr Opin Drug Discov Devel; 2008 Nov; 11(6):829-52. PubMed ID: 18946847 [TBL] [Abstract][Full Text] [Related]
27. The discovery of antibacterial agents using diversity-oriented synthesis. Galloway WR; Bender A; Welch M; Spring DR Chem Commun (Camb); 2009 May; (18):2446-62. PubMed ID: 19532856 [TBL] [Abstract][Full Text] [Related]
29. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds. Nefzi A; Appel J; Arutyunyan S; Houghten RA Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841 [TBL] [Abstract][Full Text] [Related]
30. Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy. Larsen SB; Omkvist DH; Brodin B; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS ChemMedChem; 2009 Sep; 4(9):1439-45. PubMed ID: 19557803 [TBL] [Abstract][Full Text] [Related]
31. Utilizing a library of synthetic affinity ligands for the enrichment, depletion and one-step purification of leech proteins. Dong D; Gui Y; Chen D; Li R J Mol Recognit; 2008; 21(3):163-8. PubMed ID: 18438961 [TBL] [Abstract][Full Text] [Related]
32. Organocatalysis in organic synthesis. Hegedus LS J Am Chem Soc; 2009 Dec; 131(50):17995-7. PubMed ID: 20000854 [No Abstract] [Full Text] [Related]
33. Design and Synthesis of New Pyrazole-Based Heterotricycles and their Derivatization by Automated Library Synthesis. Fricero P; Bialy L; Czechtizky W; Méndez M; Harrity JPA ChemMedChem; 2020 Sep; 15(17):1634-1638. PubMed ID: 32427423 [TBL] [Abstract][Full Text] [Related]
34. Very large virtual compound spaces: construction, storage and utility in drug discovery. Peng Z Drug Discov Today Technol; 2013 Sep; 10(3):e387-94. PubMed ID: 24050135 [TBL] [Abstract][Full Text] [Related]
35. Elucidation of the structure-property relationship of p-type organic semiconductors through rapid library construction via a one-pot, Suzuki-Miyaura coupling reaction. Fuse S; Matsumura K; Wakamiya A; Masui H; Tanaka H; Yoshikawa S; Takahashi T ACS Comb Sci; 2014 Sep; 16(9):494-9. PubMed ID: 25090049 [TBL] [Abstract][Full Text] [Related]
36. Virtual screening - what does it give us? Köppen H Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741 [TBL] [Abstract][Full Text] [Related]
37. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. Blum LC; Reymond JL J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099 [TBL] [Abstract][Full Text] [Related]
38. Reactions in the conjugated 'ene-ene-yne' manifold: five-membered ring fragmentation and ring formation via coarctate/pseudocoarctate mechanisms. Shirtcliff LD; McClintock SP; Haley MM Chem Soc Rev; 2008 Feb; 37(2):343-64. PubMed ID: 18197350 [TBL] [Abstract][Full Text] [Related]
39. Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases. Severino B; Santagada V; Perissutti E; Fiorino F; Frecentese F; De Angelis F; Esposito A; Caliendo G Mini Rev Med Chem; 2009 Jun; 9(6):653-63. PubMed ID: 19519491 [TBL] [Abstract][Full Text] [Related]
40. Recent progress in fragment-based lead discovery. Schulz MN; Hubbard RE Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]